ASR Vermogensbeheer N.V. Boosts Holdings in Zoetis Inc. $ZTS

ASR Vermogensbeheer N.V. raised its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 0.4% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 31,145 shares of the company’s stock after purchasing an additional 109 shares during the period. ASR Vermogensbeheer N.V.’s holdings in Zoetis were worth $4,857,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the business. Nuveen LLC purchased a new position in shares of Zoetis during the 1st quarter worth approximately $616,375,000. Mackenzie Financial Corp increased its position in Zoetis by 4,158.3% during the first quarter. Mackenzie Financial Corp now owns 1,824,967 shares of the company’s stock worth $300,481,000 after buying an additional 1,782,110 shares in the last quarter. Sarasin & Partners LLP purchased a new position in Zoetis during the first quarter worth $255,842,000. Polen Capital Management LLC increased its position in Zoetis by 17.6% during the 1st quarter. Polen Capital Management LLC now owns 8,796,847 shares of the company’s stock worth $1,448,401,000 after purchasing an additional 1,313,653 shares in the last quarter. Finally, Amundi increased its position in Zoetis by 30.8% during the 1st quarter. Amundi now owns 3,595,628 shares of the company’s stock worth $575,691,000 after purchasing an additional 846,909 shares in the last quarter. 92.80% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms recently commented on ZTS. Leerink Partners cut Zoetis from an “outperform” rating to a “market perform” rating and dropped their price objective for the stock from $180.00 to $155.00 in a research report on Thursday, July 17th. Leerink Partnrs downgraded shares of Zoetis from a “strong-buy” rating to a “hold” rating in a report on Thursday, July 17th. Stifel Nicolaus cut shares of Zoetis from a “buy” rating to a “hold” rating and lowered their target price for the stock from $165.00 to $160.00 in a research note on Wednesday, June 18th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Zoetis in a research note on Saturday, September 27th. Finally, Piper Sandler lifted their target price on shares of Zoetis from $210.00 to $215.00 and gave the stock an “overweight” rating in a research note on Monday, August 11th. Five analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, Zoetis has a consensus rating of “Moderate Buy” and an average target price of $200.88.

Zoetis Stock Performance

Shares of ZTS stock opened at $146.45 on Friday. Zoetis Inc. has a one year low of $139.34 and a one year high of $196.55. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.04 and a current ratio of 1.76. The company has a 50 day moving average price of $149.79 and a 200 day moving average price of $155.14. The firm has a market capitalization of $64.91 billion, a price-to-earnings ratio of 25.21, a price-to-earnings-growth ratio of 2.35 and a beta of 0.90.

Zoetis (NYSE:ZTS) last released its quarterly earnings data on Tuesday, August 5th. The company reported $1.76 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.14. The business had revenue of $2.46 billion during the quarter, compared to the consensus estimate of $2.41 billion. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The business’s revenue for the quarter was up 4.2% on a year-over-year basis. During the same period in the prior year, the firm posted $1.56 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Sell-side analysts anticipate that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.